Skip to content
My WebMD Sign In, Sign Up

Hepatitis Health Center

Font Size

High Cost of Hepatitis C Drug Sovaldi Investigated


WebMD News from HealthDay

July 14, 2014 -- An investigation into the pricing of the hepatitis C drug Sovaldi has been launched by the U.S. Senate Finance Committee.

The drug -- made by Gilead Sciences Inc. -- costs about $1,000 a pill, or about $84,000 for a patient on a standard, 12-week treatment schedule, the Wall Street Journal reported.

On Friday, the senate committee sent a letter to Gilead announcing the investigation and requesting documents on how the company decided on the price, which has been widely criticized.

"Although Sovaldi has the potential to help people with HCV, at $1,000 per pill, its pricing has raised serious concerns about the extent to which the market for this drug is operating efficiently and rationally," the letter stated. "Given the impact Sovaldi's cost will have on Medicare, Medicaid and other federal spending, we need a better understanding of how your company arrived at the price for this drug."

The letter noted that Sovaldi is offered at steep discounts in some other countries. For example, it can be up to 99 percent cheaper in Egypt than in the United States, WSJ reported.

Gilead has received the letter and will cooperate with the investigation, a company spokeswoman said. Previously, Gilead has said Sovaldi's high price reflects its effectiveness at curing hepatitis C infection.

Today on WebMD

Hepatitus C virus
Slideshow
young couple
Article
 
Hepatitis Basics
Article
Hepatitis Prevent 10
Article
 
Hepatitis C Treatment
Article
Syringes and graph illustration
Tool
 
liver illustration
Quiz
passport, pills and vaccine
Slideshow
 
Scientist looking in microscope
Slideshow
Fatty Liver Disease
Article
 
Digestive Diseases Liver Transplantation
Article
Picture Of The Liver
Image Collection
 

WebMD Special Sections